GRI Bio, Inc.
GRI
$1.51
-$0.02-1.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.47M | 4.32M | 4.57M | 8.25M | 8.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 0.00 | -250.00K | -250.00K | -250.00K |
| Total Operating Expenses | 8.24M | 8.31M | 8.37M | 12.04M | 11.14M |
| Operating Income | -8.24M | -8.31M | -8.37M | -12.04M | -11.14M |
| Income Before Tax | -12.07M | -8.26M | -8.28M | -12.77M | -13.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.07 | -8.26 | -8.28 | -12.77 | -13.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.07M | -8.26M | -8.28M | -12.77M | -13.04M |
| EBIT | -8.24M | -8.31M | -8.37M | -12.04M | -11.14M |
| EBITDA | -8.23M | -8.30M | -8.36M | -12.04M | -11.13M |
| EPS Basic | -203.88 | -315.10 | -422.76 | -458.28 | -476.32 |
| Normalized Basic EPS | -124.99 | -122.51 | -115.38 | -63.15 | -- |
| EPS Diluted | -211.74 | -315.10 | -422.76 | -458.28 | -476.32 |
| Normalized Diluted EPS | -124.99 | -122.51 | -115.38 | -63.15 | -- |
| Average Basic Shares Outstanding | 722.50K | 231.50K | 45.60K | 18.70K | -- |
| Average Diluted Shares Outstanding | 722.50K | 249.60K | 81.80K | 73.00K | 72.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |